| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
30,276 |
26,673 |
$1.50M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
10,651 |
10,613 |
$966K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,274 |
4,167 |
$271K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,206 |
6,778 |
$221K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,947 |
5,257 |
$189K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,930 |
1,927 |
$144K |
| Q3014 |
Telehealth originating site facility fee |
3,345 |
2,575 |
$95K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,189 |
2,023 |
$49K |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
2,249 |
2,078 |
$35K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,798 |
1,675 |
$23K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,595 |
1,578 |
$14K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
968 |
791 |
$13K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
831 |
694 |
$12K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
969 |
853 |
$11K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
472 |
445 |
$10K |
| 97597 |
|
134 |
100 |
$7K |
| 81003 |
|
1,697 |
1,639 |
$4K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
624 |
487 |
$4K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
108 |
108 |
$3K |
| 86580 |
|
302 |
291 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
26 |
26 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
84 |
70 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
27 |
26 |
$547.10 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
19 |
18 |
$109.62 |
| 81025 |
|
15 |
15 |
$52.50 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
80 |
73 |
$4.08 |